Document is current
Any future updates will be listed below
-
Authors
Katsarelias, Dimitrios
Isaksson, Karolin
Olofsson Bagge, Roger
- License Information
-
More Information
Article History
Received: 8 August 2019
First Online: 29 August 2019
Disclosures
: Roger Olofsson Bagge has received research grants from AstraZeneca, speaker honorarium from Roche and Pfizer, and has served on advisory boards for Amgen, BMS, and MSD (the advisory boards for BMS and MSD related to adjuvant treatment of melanoma). Dimitrios Katsarelias and Karolin Isaksson have no conflicts of interest to declare.
Free to read: This content has been made available to all.
